Hypochlorous acid generates Nε-(carboxymethyl)lysine from Amadori products

Free Radical Research

Volumn 41, Issue 6, 2007, Pages 713-718

  Mera, Katsumi ^a   Nagai, Ryoji ^a   Haraguchi, Nozomu ^a   Fujiwara, Yukio ^a   Araki, Tomohiro ^b   Sakata, Noriyuki ^c   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products (AGEs); Atherosclerosis; N (carboxymethyl)lysine (CML); Neutrophils

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; HUMAN SERUM ALBUMIN; HYPOCHLOROUS ACID; SCAVENGER;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; NEUTROPHIL; PH; STATISTICAL ANALYSIS;

ACETALDEHYDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOCHLOROUS ACID; LYSINE; NEUTROPHILS; OXIDATION-REDUCTION; SERUM ALBUMIN;

EID: 34249801223     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760701332425     Document Type: Article

References (30)

1. Brownlee, M., Cerami, A. and Vlassara, H. (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med, 318, pp. 1315-1321.
2. Vlassara, H., Brownlee, M., Manogue, KR, Dinarello, CA and Pasagian, A. (1988) Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science, 240, pp. 1546-1548.
3. Goldin, A., Beckman, JA, Schmidt, AM and Creager, MA (2006) Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation, 114, pp. 597-605.
4. Kaneto, H., Fujii, J., Suzuki, K., Kasai, H., Kawamori, R., Kamada, T. and Taniguchi, N. (1994) DNA cleavage induced by glycation of Cu, Zn-superoxide dismutase. Biochem J, 304, pp. 219-225.
5. Yan, SD, Schmidt, AM, Anderson, GM, Zhang, J., Brett, J., Zou, YS, Pinsky, D. and Stern, D. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/ binding proteins. J Biol Chem, 269, pp. 9889-9897.
6. Ikeda, K., Higashi, T., Sano, H., Jinnouchi, Y., Yoshida, M., Araki, T., Ueda, S. and Horiuchi, S. (1996) N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry, 35, pp. 8075-8083.
7. Reddy, S., Bichler, J., Wells-Knecht, KJ, Thorpe, SR and Baynes, JW (1995) N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. biochemistry, 34, pp. 10872-10878.
8. Makino, H., Shikata, K., Hironaka, K., Kushiro, M., Yamasaki, Y., Sugimoto, H., Ota, Z., Araki, N. and Horiuchi, S. (1995) Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int, 48, pp. 517-526.
9. Imai, N., Nishi, S., Suzuki, Y., Karasawa, R., Ueno, M., Shimada, H., Kawashima, S., Nakamaru, T., Miyakawa, Y., Araki, N., Horiuchi, S., Gejyo, F. and Arakawa, M. (1997) Histological localization of advanced glycosylation end products in the progression of diabetic nephropathy. Nephron, 76, pp. 153-160.
10. Suzuki, D., Yagame, M., Jinde, K., Naka, R., Yano, N., Endoh, M., Kaneshige, H., Nomoto, Y. and Sakai, H. (1996) Immunofluorescence staining of renal biopsy samples in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus using monoclonal antibody to reduced glycated lysine. J Diabetes Complications, 10, pp. 314-319.
11. Murata, T., Nagai, R., Ishibashi, T., Inomuta, H., Ikeda, K. and Horiuchi, S. (1997) The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia, 40, pp. 764-769.
12. Kume, S., Takeya, M., Mori, T., Araki, N., Suzuki, H., Horiuchi, S., Kodama, T., Miyauchi, Y. and Takahashi, K. (1995) Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol, 147, pp. 654-667.
13. Sakata, N., Imanaga, Y., Meng, J., Tachikawa, Y., Takebayashi, S., Nagai, R. and Horiuchi, S. (1999) Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease. Atherosclerosis, 142, pp. 67-77.
14. Sakata, N., Imanaga, Y., Meng, J., Tachikawa, Y., Takebayashi, S., Nagai, R., Horiuchi, S., Itabe, H. and Takano, T. (1998) Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions. Atherosclerosis, 141, pp. 61-75.
15. Nagai, R., Ikeda, K., Higashi, T., Sano, H., Jinnouchi, Y., Araki, T. and Horiuchi, S. (1997) Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product. Biochem Biophys Res Commun, 234, pp. 167-172.
16. Nagai, R., Unno, Y., Hayashi, MC, Masuda, S., Hayase, F., Kinae, N. and Horiuchi, S. (2002) Peroxynitrite induces formation of N(epsilon)-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: Novel pathways for protein modification by peroxynitrite. Diabetes, 51, pp. 2833-2839.
17. Kislinger, T., Huber, B., Taguchi, A., Yan, S Du, Hofmann, M., Yan, SF, Pischetsrieder, M., Stern, D. and Schmidt, AM (1999) N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem, 274, pp. 31740-31749.
18. Alikhani, Z., Alikhani, M., Boyd, CM, Nagao, K., Trackman, PC and Graves, DT (2005) Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J Biol Chem, 280, pp. 12087-12095.
19. Degenhardt, TP, Alderson, NL, Arrington, DD, Beattie, RJ, Basgen, JM, Steffes, MW, Thorpe, SR and Baynes, JW (2002) Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int, 61, pp. 939-950.
20. Miyata, T., de Strihou, C van Ypersele, Kurokawa, K. and Baynes, JW (1999) Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int, 55, pp. 389-399.
21. Schleicher, ED, Wagner, E. and Nerlich, AG (1997) Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest, 99, pp. 457-468.
22. Anderson, MM, Requena, JR, Crowley, JR, Thorpe, SR and Heinecke, JW (1999) The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: A mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest, 104, pp. 103-113.
23. Anderson, MM, Hazen, SL, Hsu, FF and Heinecke, JW (1997) Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha, beta-unsaturated aldehydes by phagocytes at sites of inflammation. J Clin Invest, 99, pp. 424-432.
24. Nagai, R., Hayashi, CM, Xia, L., Takeya, M. and Horiuchi, S. (2002) Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins. J Biol Chem, 277, pp. 48905-48912.
25. Chen, RF (1967) Removal of fatty acids from serum albumin by charcoal treatment. J Biol Chem, 242, pp. 173-181.
26. Nagai, R., Matsumoto, K., Ling, X., Suzuki, H., Araki, T. and Horiuchi, S. (2000) Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes, 49, pp. 1714-1723.
27. Daugherty, A., Dunn, JL, Rateri, DL and Heinecke, JW (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest, 94, pp. 437-444.
28. Hazell, LJ, Arnold, L., Flowers, D., Waeg, G., Malle, E. and Stocker, R. (1996) Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest, 97, pp. 1535-1544.
29. Palinski, W., Koschinsky, T., Butler, SW, Miller, E., Vlassara, H., Cerami, A. and Witztum, JL (1995) Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscler Thromb Vasc Biol, 15, pp. 571-582.
30. Wagner, Z., Molnar, M., Molnar, GA, Tamasko, M., Laczy, B., Wagner, L., Csiky, B., Heidland, A., Nagy, J. and Wittmann, I. (2006) Serum carboxymethyllysine predicts mortality in hemodialysis patients. Am J Kidney Dis, 47, pp. 294-300.